Oct 9 (Reuters) - :
* Canaccord Genuity cuts Edwards Lifesciences target price to $109 from
$123; rating buy For a summary of rating and price target changes on U.S. companies:
Reuters Eikon users, click on
Reuters 3000Xtra users, double-click
Reuters Station users, click .1568
For a summary of rating and price target changes on Canadian companies:
Reuters Eikon users, click on
Reuters 3000Xtra users, double-click
Reuters Station users, click .4899
((Bangalore Equities Newsdesk +91 80 4135 5800; within U.S. +1 646 223 8780))
((Bangalore Newsroom; +1 646 223 8780))